Cite
MLA Citation
Markus Kieler et al.. “A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid.” Therapeutic advances in medical oncology, vol. 11, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100099956575.0x000084